cerebellar

(redirected from cerebellar atrophy)
Also found in: Medical.
Related to cerebellar atrophy: cerebellum, Cerebral atrophy

cer·e·bel·lum

 (sĕr′ə-bĕl′əm)
n. pl. cer·e·bel·lums or cer·e·bel·la (-bĕl′ə)
The trilobed structure of the brain, lying posterior to the pons and medulla oblongata and inferior to the occipital lobes of the cerebral hemispheres, that is responsible for the regulation and coordination of complex voluntary muscular movement as well as the maintenance of posture and balance.

[Medieval Latin, from Latin, diminutive of cerebrum, brain; see ker- in Indo-European roots.]

cer′e·bel′lar (-bĕl′ər) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.cerebellar - relating to or associated with the cerebellum; "cerebellar artery"
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

cerebellar

adj cerebeloso
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
The MRI of his head revealed cerebellar atrophy (figure 1).
An interesting observation in our study is the presence of cerebellar atrophy in 15.2% of our patients in the absence of cerebellar signs.
TAIPEI, Taiwan, July 7, 2018 (translated from Chinese) -- Steminent Biotherapeutics announced that a new stem cell test for neurodegenerative cerebellar atrophy has been approved by the U.S.
TAIPEI, Taiwan, July 7, 2018 (translated from Chinese)--Steminent Biotherapeutics announced that a new stem cell test for neurodegenerative cerebellar atrophy has been approved by the U.S.
In 2016, the Japanese listed company Repro-CELL was authorized to jointly develop the Japanese market for a cerebellar atrophy treatment.
Axonal neuropathy was demonstrable on electrophysiological testing in 50% of patients, while all of them had cerebellar atrophy. But all these patients had benefited from gluten-free diet [8].
Magnetic resonance imaging (MRI) shows cerebellar atrophy that preferentially affects the anterior and dorsal vermis (lobules VI, VIIa and VIIb) and laterally predominantly affects crus I.
In addition, they had a severe developmental delay, but no dyskinesia, and their brain MRI revealed cerebellar atrophy that was not a feature of previously reported heterozygous mutations (4).
of Patients (Percentage) 1) Periventricular leukomalacia 39 (40%) and hypomyelination 2) Malformation of cortical 5 (5.1%) development 3) Corpus callosum abnormality 42 (43.3%) 4) Diffuse cerebral atrophy, 53 (54.6%) cerebellar atrophy and gliosis 5) Arnold-Chiari and Dandy-Walker 4 (4.1%) syndrome 6) Thalamus and Globus Pallidus 11 (11.1%) lesion 7) Vascular abnormality 1 (1.03%) 8) Perinatal asphyxia changes 87 (89.7%)
Brain MRI revealed cerebral and/or cerebellar atrophy in 43% in their patients.[19] Our patient presented with the typical clinical features of MERRF, including a long-standing history of muscle weakness, epileptic seizure, and clonic episodes.
Keywords: Crossed cerebellar diaschisis, magnetic resonance imaging, cerebellar atrophy
Five (2.27%) of the patients had cerebellar atrophy. Within cerebellar atrophy group of patients; three of them had accompanying cerebral atrophy; whereas two of them were isolated cerebellar atrophy.

Full browser ?